Collaborative learning and response to opioid misuse and HIV prevention in Ukraine during war.
Collaborative learning and response to opioid misuse and HIV prevention in Ukraine during war.
复制标题
DOI:
10.1016/s2215-0366(22)00318-2
复制
发表时间:
2022-11
影响因子:
64.3
通讯作者:
Madden, Lynn M.
中科院分区:
文献类型:
--
作者:
Altice, Frederick L.;Bromberg, Daniel J.;Klepikov, Adriy;Barzilay, Ezra J.;Islam, Zahedul;Dvoriak, Sergii;Farnum, Scott;Madden, Lynn M.
An estimated 346 000 people who inject drugs reside in Ukraine, 65 795 (19%) of whom are infected with HIV, 1 making Ukraine’s intertwined opioid and HIV epidemics among the worst globally. Scale-up of maintenance with opioid agonist therapy (OAT), such as methadone and buprenorphine, is the most effective strategy for controlling Ukraine’s HIV epidemic. 2 ByFeb 24, 2022, Ukraine had 17 232 people on OAT, with targets set for 25 886 people being enrolled by the end of the year. Several activities in Ukraine since the first invasion by Russia in 2014 helped prepare Ukraine, a country with an inflexible health-care system, to respond to changing HIV prevention needs, including the introduction of the Network for the Improvement of Addiction Treatment (NIATx) in 2014. NIATx, a collaborative learning strategy that supports addiction treatment experts in their regional responses to OAT scale-up, is a bundle of implementation tools used for process improvement that rapidly identifies barriers and facilitators, creates collaborative learning groups, and facilitates efficiencies through rapidcycle change projects. NIATx regularly brings local and regional OAT providers together to discuss real-time issues, which evolve in their practice, and to jointly solve problems as they arise. By 2016, NIATx had created efficiencies in OAT delivery3 that informed Ukraine’s Public Health Centre to recommend major revisions to Order 200, the legislation that guides OAT delivery. 3 These revisions removed many treatment barriers, 4 loosened requirements from daily supervision to takehome doses for 10 days for patients whose symptoms had stabilised, and allowed OAT prescription outside of specialty clinics, including in primary care5 and nongovernmental clinics. 6 NIATx supported OAT providers to optimise financial incentives when the new National Health-care System reform started in 2020, which provided capitated economic incentives for clinics providing OAT. It also supported OAT providers during the COVID-19 pandemic when Ukraine’s Public Health Centre recommended greater flexibility with take-home dosing, which in turn increased clinical time for staff to enrol new patients, use telehealth, and avoid overdoses with take-home dosing. 7